Scientists trace a gene that triggers cancer
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Scientists shed new light yesterday on why a single gene can trigger breast cancer in 80 per cent of women who carry it.
In healthy women, the BRCA-1 gene, found on chromosome 17, helps the body to detect potentially cancerous cells and forces them to self- destruct. But researchers at Queen's University, Belfast say that when the gene is faulty, the "radar" system is blinded and tumours develop. Women who inherit a mutation in the BRCA-1 gene are known to have a 65 to 85 per cent chance of developing breast cancer.
They also have a 40 per cent chance of ovarian cancer by the age of 70. But the role the gene plays in this elevated risk is not fully understood. Dr Paul Harkin and colleagues at Queen's used the latest technology to study thousands of cells containing normal BRCA-1 genes and cells with defective genes.
In normal circumstances, the gene interacts with a chemical called interferon gamma, the "eyes and ears" of the immune system, and scours the body for diseased cells, which are killed off.
When the BRCA-1 gene is dysfunctional, the surveillance system appears to break down. But by adding a healthy copy of the BRCA-1 gene, the researchers were able to restore the surveillance system.
Sir Paul Nurse, chief executive of Cancer Research UK, which supported the work, said: "We need to understand why one faulty gene can make such a big difference. Dr Harkin and his team are bringing us closer to this aim."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments